The Ambio5™ is our 3RD generation amniotic membrane technology – developed to further optimize and simplify amniotic membrane transplantation (AMT) for eye surgery. The safety, logistical and surgical advantages with Ambio5 are vast.
Features and Benefits
Thicker, More Biostructurally Intact Matrix
Ambio5 was developed to yield a substantially thicker, more intact, native amniotic membrane allograft. While the proprietary tissue process destroys potential bioburden and virulency, the membrane's devitalized cellular components - along with its dense adjacent and connective matrices - are preserved.
Tissue Safety
All tissues recovered meet stringent specifications related to donor screening and testing. Ambio5™ allografts are procured and processed according to standards established by the American Association of Tissue Banks (AATB) and the United States F.D.A and are subject to unyielding high standards to ensure tissue safety.
Tissue Quality
Each allograft is processed, sterilized and packaged with proprietary, device-like methods – to ensure consistent, high quality tissue for transplantation.
Simple Storage and Preparation
Ambio5 Allografts are provided dehydrated for room-temp storage. No freezing or refrigeration required. Ambio5 activates with sterile saline within minutes. No thawing or soaks required.
Faster Surgery
Significantly less surgical time is required. Ambio5 Allografts are processed and packaged WITHOUT a filter paper or "substrate" backing. The tissue can be trimmed and contoured in its dry state and then hydrated during surgery within minutes.
AmbioDry, AmbioDry2, Ambio5 are trademarks of OKTO Ophtho
|
